Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Mar, 2020 | Pages:
120 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global controlled release drug delivery market size is estimated to reach USD 69.8 billion by 2027 registering a CAGR of 7.8% during the forecast period, according to a new report by Grand View Research, Inc. The benefits associated with controlled release drug delivery systems, such as increased therapeutic efficacy, less side effects, and low treatment cost are the factors driving the market growth. These technologies offer various benefits over traditional delivery forms, such as reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels. Presence of multiple in-vivo biological barriers that affects the absorption, bioavailability, and stability of the drug has open wide horizon for the controlled release drug delivery products. For instance, controlled release drug delivery system has enabled delivery of even large and complex molecules such as DNA/RNA, proteins and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run. Rapidly increasing geriatric and pediatric population is one of the major factors fueling the demand for controlled release drug delivery systems, due to high cases prescription non-adherence in this age-group. Innovations in various drug delivery systems has been providing geriatric and pediatric population with easy solutions, which are further propelling the market. Controlled release of drug delivery systems can be altered according to required dosage over a specific period of time. Further key findings from the report suggest: • Based on application, oral controlled release systems held the largest market share in 2019 owing to increasing usage and ease of convenience offered for administration of medication • Targeted drug delivery is poised to be the fastest growing technology segment during the forecast period owing to various benefits of the technology, such as increased safety and therapeutic efficacy • Osmotic delivery is projected to witness the fastest CAGR in the activation modulation drug delivery systems during the forecast period, due to the ability of this release mechanism to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility • North America held the largest market share in 2019 owing to the presence of developed healthcare infrastructure facilities, increasing R&D activities and existence of major market players • Asia Pacific is expected to post the highest CAGR during the forecast period owing to rising investments by dominant players in the region along with developments in the of pharmaceutical industry in emerging countries, such as India and China • Some of the prominent companies operating in the controlled release drug delivery market are Orbis Biosciences, Inc.; Merck and Co., Inc.; Alkermes plc; Johnson and Johnson; Coating Place, Inc.; Corium International, Inc.; Depomed, Inc.; Pfizer, Inc; Aradigm Corporation; and Capsugel
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Release mechanism
1.1.3. Application
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Release mechanism outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Controlled release drug delivery Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increase in need for controlled release dosage forms for pediatric and geriatric population
3.4.1.2. Increased compliance due to nature of dosage forms
3.4.2. Market restraint analysis
3.4.2.1. Limited amount of controlled release dosage forms is acceptable for usage in pediatric conditions
3.4.2.2. Need for high dose of active pharmaceutical ingredient
3.5. Controlled Release Drug Delivery Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Global controlled release drug delivery Market: Technology Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Wurster technique
4.1.2. Coacervation
4.1.3. Micro encapsulation
4.1.4. Implants
4.1.5. Transdermal
4.1.6. Targeted delivery
4.1.7. Others
4.2. controlled release drug delivery Market Share, 2019 & 2027
4.3. Segment Dashboard
4.4. Global controlled release drug delivery Market by Technology Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Wurster technique
4.5.1.1. Wurster technique controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.2. Coacervation
4.5.2.1. Coacervation controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.3. Micro Encapsulation
4.5.3.1. Micro encapsulation controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.4. Implants
4.5.4.1. Implants controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.5. Transdermal
4.5.5.1. Transdermal controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.6. Targeted delivery
4.5.6.1. Targeted delivery controlled release drug delivery market, 2016 - 2027 (USD Million)
4.5.7. Others
4.5.7.1. Others controlled release drug delivery market, 2016 - 2027 (USD Million)
Chapter 5. Global controlled release drug delivery Market: Release Mechanism Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Polymer Based Systems
5.1.2. Micro Reservoir Partition Controlled Drug Delivery Systems
5.1.3. Feedback Regulated Drug Delivery Systems
5.1.4. Activation-modulated Drug Delivery Systems
5.1.4.1. Osmotic Pressure Activated
5.1.4.2. Hydrodynamic Pressure Activated
5.1.4.3. Vapor Pressure Activated
5.1.4.4. Mechanically Activated
5.1.4.5. Magnetically Activated
5.1.5. Chemically Activated
5.1.5.1. pH Activated
5.1.5.2. Hydrolysis Activated
5.1.5.3. Enzyme Activated
5.2. controlled release drug delivery Market Share, 2019 & 2027
5.3. Segment Dashboard
5.4. Global controlled release drug delivery Market by Release Mechanism Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. Polymer based systems
5.5.1.1. Polymer based systems controlled release drug delivery market, 2016 - 2027 (USD Million)
5.5.2. Micro reservoir partition controlled drug delivery systems
5.5.2.1. Micro reservoir partition controlled drug delivery systems market, 2016 - 2027 (USD Million)
5.5.3. Feedback regulated drug delivery systems
5.5.3.1. Feedback regulated drug delivery systems market, 2016 - 2027 (USD Million)
5.5.4. Activation-modulated drug delivery systems
5.5.4.1. Activation-modulated drug delivery systems market, 2016 - 2027 (USD Million)
5.5.4.2. Osmotic pressure activated systems market, 2016 - 2027 (USD Million)
5.5.4.3. Hydrodynamic pressure activated systems market, 2016 - 2027 (USD Million)
5.5.4.4. Vapor pressure activated systems market, 2016 - 2027 (USD Million)
5.5.4.5. Mechanically activated systems market, 2016 - 2027 (USD Million)
5.5.4.6. Magnetically activated systems market, 2016 - 2027 (USD Million)
5.5.5. Chemically activated
5.5.5.1. pH activated controlled release drug delivery market, 2016 - 2027 (USD Million)
5.5.5.2. Hydrolysis activated controlled release drug delivery market, 2016 - 2027 (USD Million)
5.5.5.3. Enzyme activated controlled release drug delivery market, 2016 - 2027 (USD Million)
Chapter 6. Global controlled release drug delivery Market: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Metered Dose Inhalers
6.1.2. Injectable
6.1.3. Transdermal and Ocular Patches
6.1.4. Infusion Pumps
6.1.5. Oral Controlled-drug delivery Systems
6.1.6. Drug Eluting Stents
6.2. controlled release drug delivery Market Share, 2019 & 2027
6.3. Segment Dashboard
6.4. Global controlled release drug delivery Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
6.5.1. Metered dose inhalers
6.5.1.1. Metered dose inhaler controlled release drug delivery market, 2016 - 2027 (USD Million)
6.5.2. Injectable
6.5.2.1. Injectable controlled release drug delivery market, 2016 - 2027 (USD Million)
6.5.3. Transdermal and ocular patches
6.5.3.1. Transdermal and ocular patches controlled release drug delivery market, 2016 - 2027 (USD Million)
6.5.4. Infusion Pumps
6.5.4.1. Infusion pumps controlled release drug delivery market, 2016 - 2027 (USD Million)
6.5.5. Oral controlled release drug delivery system
6.5.5.1. Oral controlled release drug delivery market, 2016 - 2027 (USD Million)
6.5.6. Drug eluting stents
6.5.6.1. Drug eluting stents controlled release drug delivery market, 2016 - 2027 (USD Million)
Chapter 7. Global controlled release drug delivery Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2019 & 2027
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2019
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8. Europe
7.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.2. U.K.
7.8.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.3. Germany
7.8.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.4. France
7.8.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.5. Italy
7.8.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.6. Spain
7.8.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.7. Russia
7.8.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.8. Switzerland
7.8.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.9. The Netherland
7.8.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.10. Sweden
7.8.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.11. Belgium
7.8.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.8.12. Others
7.8.12.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9. Asia Pacific
7.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.2. Japan
7.9.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.3. China
7.9.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.4. India
7.9.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.5. South Korea
7.9.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.6. Thailand
7.9.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.7. Indonesia
7.9.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.8. Philippines
7.9.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.9. Vietnam
7.9.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.10. Malaysia
7.9.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.11. Singapore
7.9.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.9.12. Others
7.9.12.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10. Latin America
7.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.2. Brazil
7.10.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.3. Mexico
7.10.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.4. Argentina
7.10.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.5. Colombia
7.10.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.6. Chile
7.10.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.10.7. Others
7.10.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.4. Kuwait
7.11.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.5. Israel
7.11.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
7.11.6. Others
7.11.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.2.2. Market Leaders
8.2.3. Emerging Players
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2019
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company market share/ranking, by region
8.4.3. Competitive dashboard analysis
8.4.3.1. Market differentiators
8.4.3.2. Synergy analysis: major deals and strategic alliances
8.5. Private Companies
8.5.1. List of key emerging companies/technology disruptors/innovators
8.5.2. Funding outlook
8.5.3. Regional network map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.5.5. Supplier ranking
8.5.6. Key company profiled
8.5.7. Depomed, Inc.
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Coating Place, Inc.
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Corium International, Inc.
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Johnson and Johnson Services, Inc.
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic Initiative
8.5.11. Alkermes plc
8.5.11.1. Company overview
8.5.11.2. Financial performance
8.5.11.3. Product benchmarking
8.5.11.4. Strategic initiatives
8.5.12. Pfizer, Inc.
8.5.12.1. Company overview
8.5.12.2. Financial performance
8.5.12.3. Product benchmarking
8.5.12.4. Strategic initiatives
8.5.13. Orbis Biosciences, Inc.
8.5.13.1. Company overview
8.5.13.2. Financial performance
8.5.13.3. Product benchmarking
8.5.13.4. Strategic initiatives
8.5.14. Capsugel
8.5.14.1. Company overview
8.5.14.2. Financial performance
8.5.14.3. Product benchmarking
8.5.14.4. Strategic initiatives
8.5.15. Merck and Co., Inc.
8.5.15.1. Company overview
8.5.15.2. Financial performance
8.5.15.3. Product benchmarking
8.5.15.4. Strategic initiatives
8.5.16. Aradigm Corporation
8.5.16.1. Company overview
8.5.16.2. Financial performance
8.5.16.3. Product benchmarking
8.5.16.4. Strategic initiatives
List of Tables Table 1 List of Abbreviation Table 2 North America controlled release drug delivery market, by region, 2016 - 2027 (USD Million) Table 3 North America controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 4 North America controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 5 North America controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 6 U.S. controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 7 U.S. controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 8 U.S. controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 9 Canada controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 10 Canada controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 11 Canada controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 12 Europe controlled release drug delivery market, by region, 2016 - 2027 (USD Million) Table 13 Europe controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 14 Europe controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 15 Europe controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 16 Germany controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 17 Germany controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 18 Germany controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 19 U.K. controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 20 U.K. controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 21 U.K. controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 22 France controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 23 France controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 24 France controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 25 Italy controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 26 Italy controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 27 Italy controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 28 Spain controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 29 Spain controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 30 Spain controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 31 The Netherland controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 32 The Netherland controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 33 The Netherland controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 34 Switzerland controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 35 Switzerland controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 36 Switzerland controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 37 Russia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 38 Russia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 39 Russia controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 40 Sweden controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 41 Sweden controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 42 Sweden controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 43 Belgium controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 44 Belgium controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 45 Belgium controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 46 Asia Pacific controlled release drug delivery market, by region, 2016 - 2027 (USD Million) Table 47 Asia Pacific controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 48 Asia Pacific controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 49 Asia Pacific controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 50 Japan controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 51 Japan controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 52 Japan controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 53 China controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 54 China controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 55 China controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 56 India controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 57 India controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 58 India controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 59 South Korea controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 60 South Korea controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 61 South Korea controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 62 Thailand controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 63 Thailand controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 64 Thailand controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 65 Indonesia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 66 Indonesia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 67 Indonesia controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 68 Philippines controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 69 Philippines controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 70 Philippines controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 71 Vietnam controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 72 Vietnam controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 73 Vietnam controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 74 Singapore controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 75 Singapore controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 76 Singapore controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 77 Malaysia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 78 Malaysia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 79 Malaysia controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 80 Latin America controlled release drug delivery market, by region, 2016 - 2027 (USD Million) Table 81 Latin America controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 82 Latin America controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 83 Latin America controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 84 Brazil controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 85 Brazil controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 86 Brazil controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 87 Mexico controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 88 Mexico controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 89 Mexico controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 90 Argentina controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 91 Argentina controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 92 Argentina controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 93 Colombia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 94 Colombia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 95 Colombia controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 96 Chile controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 97 Chile controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 98 Chile controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 99 Middle east and Africa controlled release drug delivery market, by region, 2016 - 2027 (USD Million) Table 100 Middle east and Africa controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 101 Middle east and Africa controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 102 Middle east and Africa controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 103 South Africa controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 104 South Africa controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 105 South Africa controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 106 Saudi Arabia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 107 Saudi Arabia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 108 Saudi Arabia controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 109 UAE controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 110 UAE controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 111 UAE controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 112 Kuwait controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 113 Kuwait controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 114 Kuwait controlled release drug delivery market, by application, 2016 - 2027 (USD Million) Table 115 Israel controlled release drug delivery market, by technology, 2016 - 2027 (USD Million) Table 116 Israel controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million) Table 117 Israel controlled release drug delivery market, by application, 2016 - 2027 (USD Million) List of Figures Fig. 1 Market research process Fig. 2 Data triangulation techniques Fig. 3 Primary research pattern Fig. 4 Primary interviews in North America Fig. 5 Primary interviews in Europe Fig. 6 Primary interviews in APAC Fig. 7 Primary interviews in Latin America Fig. 8 Primary interviews in MEA Fig. 9 Market research approaches Fig. 10 Value-chain-based sizing & forecasting Fig. 11 QFD modeling for market share assessment Fig. 12 Market formulation & validation Fig. 13 controlled release drug delivery market: market outlook Fig. 14 controlled release drug delivery market competitive insights Fig. 15 Parent market outlook Fig. 16 Related/ancillary market outlook Fig. 17 Penetration and growth prospect mapping Fig. 18 Industry value chain analysis Fig. 19 controlled release drug delivery market driver impact Fig. 20 controlled release drug delivery market restraint impact Fig. 21 controlled release drug delivery market strategic initiatives analysis Fig. 22 controlled release drug delivery market: technology movement analysis Fig. 23 controlled release drug delivery market: technology outlook and key takeaways Fig. 24 Wurster technique market estimates and forecast, 2016 - 2027 Fig. 25 Coacervation market estimates and forecast, 2016 - 2027 Fig. 26 Micro encapsulation market estimates and forecast, 2016 - 2027 Fig. 27 Implants market estimates and forecast, 2016 - 2027 Fig. 28 Transdermal market estimates and forecast, 2016 - 2027 Fig. 29 Targeted delivery market estimates and forecast, 2016 - 2027 Fig. 30 Others market estimates and forecast, 2016 - 2027 Fig. 31 controlled release drug delivery market: release mechanism movement analysis Fig. 32 controlled release drug delivery market: release mechanism outlook and key takeaways Fig. 33 Polymer based systems market estimates and forecast, 2016 - 2027 Fig. 34 Micro reservoir partition-controlled drug delivery systems estimates and forecasts, 2016 - 2027 Fig. 35 Feedback regulate drug delivery systems estimates and forecasts, 2016 - 2027 Fig. 36 Activation-modulated drug delivery systems estimates and forecasts, 2016 - 2027 Fig. 37 Chemically activated drug delivery systems estimates and forecasts, 2016 - 2027 Fig. 38 controlled release drug delivery market: application movement analysis Fig. 39 controlled release drug delivery market: application outlook and key takeaways Fig. 40 Metered dose inhaler market estimates and forecasts, 2016 - 2027 Fig. 41 Injectable controlled release drug delivery market estimates and forecasts, 2016 - 2027 Fig. 42 Transdermal and Ocular patches controlled release drug delivery market estimates and forecasts, 2016 - 2027 Fig. 43 Infusion pumps controlled release drug delivery market estimates and forecasts, 2016 - 2027 Fig. 44 Oral controlled drug delivery systems market estimates and forecasts, 2016 - 2027 Fig. 45 Drug eluting stents controlled release drug delivery market estimates and forecasts, 2016 - 2027 Fig. 46 Global controlled release drug delivery market: regional movement analysis Fig. 47 Global controlled release drug delivery market: regional outlook and key takeaways Fig. 48 Global controlled release drug delivery market share and leading players Fig. 49 North America market share and leading players Fig. 50 Europe market share and leading players Fig. 51 Asia Pacific market share and leading players Fig. 52 Latin America market share and leading players Fig. 53 Middle East & Africa market share and leading players Fig. 54 North America: SWOT Fig. 55 Europe SWOT Fig. 56 Asia Pacific SWOT Fig. 57 Latin America SWOT Fig. 58 MEA SWOT Fig. 59 North America, by country Fig. 60 North America Fig. 61 North America market estimates and forecasts, 2016 - 2027 Fig. 62 U.S. Fig. 63 U.S. market estimates and forecasts, 2016 - 2027 Fig. 64 Canada Fig. 65 Canada market estimates and forecasts, 2016 - 2027 Fig. 66 Europe Fig. 67 Europe. market estimates and forecasts, 2016 - 2027 Fig. 68 U.K. Fig. 69 U.K. market estimates and forecasts, 2016 - 2027 Fig. 70 Germany Fig. 71 Germany market estimates and forecasts, 2016 - 2027 Fig. 72 France Fig. 73 France market estimates and forecasts, 2016 - 2027 Fig. 74 Italy Fig. 75 Italy market estimates and forecasts, 2016 - 2027 Fig. 76 Spain Fig. 77 Spain market estimates and forecasts, 2016 - 2027 Fig. 78 Russia Fig. 79 Russia market estimates and forecasts, 2016 - 2027 Fig. 80 The Netherlands Fig. 81 The Netherlands market estimates and forecasts, 2016 - 2027 Fig. 82 Switzerland Fig. 83 Switzerland market estimates and forecasts, 2016 - 2027 Fig. 84 Sweden Fig. 85 Sweden market estimates and forecasts, 2016 - 2027 Fig. 86 Belgium Fig. 87 Belgium market estimates and forecasts, 2016 - 2027 Fig. 88 Asia Pacific Fig. 89 Asia Pacific market estimates and forecasts, 2016 - 2027 Fig. 90 China Fig. 91 China market estimates and forecasts, 2016 - 2027 Fig. 92 Japan Fig. 93 Japan market estimates and forecasts, 2016 - 2027 Fig. 94 India Fig. 95 India market estimates and forecasts, 2016 - 2027 Fig. 96 Thailand Fig. 97 Thailand. market estimates and forecasts, 2016 - 2027 Fig. 98 South Korea Fig. 99 South Korea market estimates and forecasts, 2016 - 2027 Fig. 100 Indonesia Fig. 101 Indonesia market estimates and forecasts, 2016 - 2027 Fig. 102 Philippines Fig. 103 Philippines market estimates and forecasts, 2016 - 2027 Fig. 104 Vietnam Fig. 105 Vietnam market estimates and forecasts, 2016 - 2027 Fig. 106 Singapore Fig. 107 Singapore market estimates and forecasts, 2016 - 2027 Fig. 108 Malaysia Fig. 109 Malaysia market estimates and forecasts, 2016 - 2027 Fig. 110 Latin America Fig. 111 Latin America market estimates and forecasts, 2016 - 2027 Fig. 112 Brazil Fig. 113 Brazil market estimates and forecasts, 2016 - 2027 Fig. 114 Mexico Fig. 115 Mexico market estimates and forecasts, 2016 - 2027 Fig. 116 Argentina Fig. 117 Argentina market estimates and forecasts, 2016 - 2027 Fig. 118 Colombia Fig. 119 Colombia market estimates and forecasts, 2016 - 2027 Fig. 120 Chile Fig. 121 Chile market estimates and forecasts, 2016 - 2027 Fig. 122 Middle East and Africa Fig. 123 Middle East and Africa. market estimates and forecasts, 2016 - 2027 Fig. 124 South Africa Fig. 125 South Africa market estimates and forecasts, 2016 - 2027 Fig. 126 Saudi Arabia Fig. 127 Saudi Arabia market estimates and forecasts, 2016 - 2027 Fig. 128 UAE Fig. 129 UAE market estimates and forecasts, 2016 - 2027 Fig. 130 Kuwait Fig. 131 Kuwait market estimates and forecasts, 2016 - 2027 Fig. 132 Israel Fig. 133 Israel market estimates and forecasts, 2016 - 2027 Fig. 134 Participant categorization- controlled release drug delivery market Fig. 135 Market share of key market players- controlled release drug delivery market
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
